TECHNOLOGY IN CANCER RESEARCH & TREATMENT-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1227376, encodeId=436e122e376cb, content=偏重的研究方向：肺癌;肿瘤 经验分享：审稿3个月了，找不到审稿人，巨慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76042430158, createdName=123b4903m95暂无昵称, createdTime=Sun Jun 19 16:34:50 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227454, encodeId=c58e122e454d9, content=审稿很慢，慎投！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76042430158, createdName=123b4903m95暂无昵称, createdTime=Sun Jun 19 23:09:26 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109983, encodeId=4165210998388, content=预警风险很大啊。。。。难过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99c56511981, createdName=997xiu, createdTime=Thu Jan 12 18:17:12 CST 2023, time=2023-01-12, status=1, ipAttribution=纽约), GetPortalCommentsPageByObjectIdResponse(id=2104003, encodeId=af3721040031a, content=已经review return -awaiting editor assessment 一周了，还要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd701628022, createdName=prima, createdTime=Fri Dec 02 20:13:12 CST 2022, time=2022-12-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1204353, encodeId=807f120435326, content=Reviews returned - awaiting Editor assessment The Editor is considering the reviews and recommendations in order to make decision on your submission这个状态已经一个多月了，需要发邮件催吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34b85489817, createdName=ms1000000553606957, createdTime=Sun Mar 20 15:23:19 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104026, encodeId=3a4321040261a, content=已经review return-awaiting editor assessment一周了，还要等多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd701628022, createdName=prima, createdTime=Fri Dec 02 23:16:30 CST 2022, time=2022-12-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2103408, encodeId=f4192103408b1, content=这个是不是要预警了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=331d6510030, createdName=ms5000001864993277, createdTime=Tue Nov 29 23:02:32 CST 2022, time=2022-11-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1193528, encodeId=49f411935286d, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：接收后，为什么一直没有收到APC的invoice，哪位老师可以教我怎么缴纳版面费么，￣□￣｜｜，一直没有收到类似其他杂志的invoice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6155445710, createdName=HMB, createdTime=Tue Feb 15 10:58:18 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230573, encodeId=670a12305e38a, content=偏重的研究方向：乳腺癌 经验分享：记录一下 6月29日开始邀请审稿人 7月4日仍然还在邀请中........ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99c56511981, createdName=摩西摩西, createdTime=Mon Jul 04 22:29:43 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094465, encodeId=2751209446597, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：kp[k;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=614a8379235, createdName=ms3000000590360295, createdTime=Tue Oct 18 13:40:40 CST 2022, time=2022-10-18, status=1, ipAttribution=)]

2022-06-19 123b4903m95暂无昵称

偏重的研究方向：肺癌;肿瘤
经验分享：审稿3个月了，找不到审稿人，巨慢

57 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1227376, encodeId=436e122e376cb, content=偏重的研究方向：肺癌;肿瘤 经验分享：审稿3个月了，找不到审稿人，巨慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76042430158, createdName=123b4903m95暂无昵称, createdTime=Sun Jun 19 16:34:50 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227454, encodeId=c58e122e454d9, content=审稿很慢，慎投！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76042430158, createdName=123b4903m95暂无昵称, createdTime=Sun Jun 19 23:09:26 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109983, encodeId=4165210998388, content=预警风险很大啊。。。。难过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99c56511981, createdName=997xiu, createdTime=Thu Jan 12 18:17:12 CST 2023, time=2023-01-12, status=1, ipAttribution=纽约), GetPortalCommentsPageByObjectIdResponse(id=2104003, encodeId=af3721040031a, content=已经review return -awaiting editor assessment 一周了，还要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd701628022, createdName=prima, createdTime=Fri Dec 02 20:13:12 CST 2022, time=2022-12-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1204353, encodeId=807f120435326, content=Reviews returned - awaiting Editor assessment The Editor is considering the reviews and recommendations in order to make decision on your submission这个状态已经一个多月了，需要发邮件催吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34b85489817, createdName=ms1000000553606957, createdTime=Sun Mar 20 15:23:19 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104026, encodeId=3a4321040261a, content=已经review return-awaiting editor assessment一周了，还要等多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd701628022, createdName=prima, createdTime=Fri Dec 02 23:16:30 CST 2022, time=2022-12-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2103408, encodeId=f4192103408b1, content=这个是不是要预警了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=331d6510030, createdName=ms5000001864993277, createdTime=Tue Nov 29 23:02:32 CST 2022, time=2022-11-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1193528, encodeId=49f411935286d, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：接收后，为什么一直没有收到APC的invoice，哪位老师可以教我怎么缴纳版面费么，￣□￣｜｜，一直没有收到类似其他杂志的invoice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6155445710, createdName=HMB, createdTime=Tue Feb 15 10:58:18 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230573, encodeId=670a12305e38a, content=偏重的研究方向：乳腺癌 经验分享：记录一下 6月29日开始邀请审稿人 7月4日仍然还在邀请中........ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99c56511981, createdName=摩西摩西, createdTime=Mon Jul 04 22:29:43 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094465, encodeId=2751209446597, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：kp[k;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=614a8379235, createdName=ms3000000590360295, createdTime=Tue Oct 18 13:40:40 CST 2022, time=2022-10-18, status=1, ipAttribution=)]

2022-06-19 123b4903m95暂无昵称

审稿很慢，慎投！

60 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1227376, encodeId=436e122e376cb, content=偏重的研究方向：肺癌;肿瘤 经验分享：审稿3个月了，找不到审稿人，巨慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76042430158, createdName=123b4903m95暂无昵称, createdTime=Sun Jun 19 16:34:50 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227454, encodeId=c58e122e454d9, content=审稿很慢，慎投！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76042430158, createdName=123b4903m95暂无昵称, createdTime=Sun Jun 19 23:09:26 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109983, encodeId=4165210998388, content=预警风险很大啊。。。。难过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99c56511981, createdName=997xiu, createdTime=Thu Jan 12 18:17:12 CST 2023, time=2023-01-12, status=1, ipAttribution=纽约), GetPortalCommentsPageByObjectIdResponse(id=2104003, encodeId=af3721040031a, content=已经review return -awaiting editor assessment 一周了，还要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd701628022, createdName=prima, createdTime=Fri Dec 02 20:13:12 CST 2022, time=2022-12-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1204353, encodeId=807f120435326, content=Reviews returned - awaiting Editor assessment The Editor is considering the reviews and recommendations in order to make decision on your submission这个状态已经一个多月了，需要发邮件催吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34b85489817, createdName=ms1000000553606957, createdTime=Sun Mar 20 15:23:19 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104026, encodeId=3a4321040261a, content=已经review return-awaiting editor assessment一周了，还要等多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd701628022, createdName=prima, createdTime=Fri Dec 02 23:16:30 CST 2022, time=2022-12-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2103408, encodeId=f4192103408b1, content=这个是不是要预警了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=331d6510030, createdName=ms5000001864993277, createdTime=Tue Nov 29 23:02:32 CST 2022, time=2022-11-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1193528, encodeId=49f411935286d, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：接收后，为什么一直没有收到APC的invoice，哪位老师可以教我怎么缴纳版面费么，￣□￣｜｜，一直没有收到类似其他杂志的invoice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6155445710, createdName=HMB, createdTime=Tue Feb 15 10:58:18 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230573, encodeId=670a12305e38a, content=偏重的研究方向：乳腺癌 经验分享：记录一下 6月29日开始邀请审稿人 7月4日仍然还在邀请中........ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99c56511981, createdName=摩西摩西, createdTime=Mon Jul 04 22:29:43 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094465, encodeId=2751209446597, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：kp[k;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=614a8379235, createdName=ms3000000590360295, createdTime=Tue Oct 18 13:40:40 CST 2022, time=2022-10-18, status=1, ipAttribution=)]

2023-01-12 997xiu 来自纽约

预警风险很大啊。。。。难过

0 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1227376, encodeId=436e122e376cb, content=偏重的研究方向：肺癌;肿瘤 经验分享：审稿3个月了，找不到审稿人，巨慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76042430158, createdName=123b4903m95暂无昵称, createdTime=Sun Jun 19 16:34:50 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227454, encodeId=c58e122e454d9, content=审稿很慢，慎投！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76042430158, createdName=123b4903m95暂无昵称, createdTime=Sun Jun 19 23:09:26 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109983, encodeId=4165210998388, content=预警风险很大啊。。。。难过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99c56511981, createdName=997xiu, createdTime=Thu Jan 12 18:17:12 CST 2023, time=2023-01-12, status=1, ipAttribution=纽约), GetPortalCommentsPageByObjectIdResponse(id=2104003, encodeId=af3721040031a, content=已经review return -awaiting editor assessment 一周了，还要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd701628022, createdName=prima, createdTime=Fri Dec 02 20:13:12 CST 2022, time=2022-12-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1204353, encodeId=807f120435326, content=Reviews returned - awaiting Editor assessment The Editor is considering the reviews and recommendations in order to make decision on your submission这个状态已经一个多月了，需要发邮件催吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34b85489817, createdName=ms1000000553606957, createdTime=Sun Mar 20 15:23:19 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104026, encodeId=3a4321040261a, content=已经review return-awaiting editor assessment一周了，还要等多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd701628022, createdName=prima, createdTime=Fri Dec 02 23:16:30 CST 2022, time=2022-12-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2103408, encodeId=f4192103408b1, content=这个是不是要预警了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=331d6510030, createdName=ms5000001864993277, createdTime=Tue Nov 29 23:02:32 CST 2022, time=2022-11-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1193528, encodeId=49f411935286d, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：接收后，为什么一直没有收到APC的invoice，哪位老师可以教我怎么缴纳版面费么，￣□￣｜｜，一直没有收到类似其他杂志的invoice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6155445710, createdName=HMB, createdTime=Tue Feb 15 10:58:18 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230573, encodeId=670a12305e38a, content=偏重的研究方向：乳腺癌 经验分享：记录一下 6月29日开始邀请审稿人 7月4日仍然还在邀请中........ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99c56511981, createdName=摩西摩西, createdTime=Mon Jul 04 22:29:43 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094465, encodeId=2751209446597, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：kp[k;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=614a8379235, createdName=ms3000000590360295, createdTime=Tue Oct 18 13:40:40 CST 2022, time=2022-10-18, status=1, ipAttribution=)]

2022-12-02 prima 来自广东省

已经review return -awaiting editor assessment 一周了，还要多久啊

52 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1227376, encodeId=436e122e376cb, content=偏重的研究方向：肺癌;肿瘤 经验分享：审稿3个月了，找不到审稿人，巨慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76042430158, createdName=123b4903m95暂无昵称, createdTime=Sun Jun 19 16:34:50 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227454, encodeId=c58e122e454d9, content=审稿很慢，慎投！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76042430158, createdName=123b4903m95暂无昵称, createdTime=Sun Jun 19 23:09:26 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109983, encodeId=4165210998388, content=预警风险很大啊。。。。难过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99c56511981, createdName=997xiu, createdTime=Thu Jan 12 18:17:12 CST 2023, time=2023-01-12, status=1, ipAttribution=纽约), GetPortalCommentsPageByObjectIdResponse(id=2104003, encodeId=af3721040031a, content=已经review return -awaiting editor assessment 一周了，还要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd701628022, createdName=prima, createdTime=Fri Dec 02 20:13:12 CST 2022, time=2022-12-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1204353, encodeId=807f120435326, content=Reviews returned - awaiting Editor assessment The Editor is considering the reviews and recommendations in order to make decision on your submission这个状态已经一个多月了，需要发邮件催吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34b85489817, createdName=ms1000000553606957, createdTime=Sun Mar 20 15:23:19 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104026, encodeId=3a4321040261a, content=已经review return-awaiting editor assessment一周了，还要等多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd701628022, createdName=prima, createdTime=Fri Dec 02 23:16:30 CST 2022, time=2022-12-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2103408, encodeId=f4192103408b1, content=这个是不是要预警了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=331d6510030, createdName=ms5000001864993277, createdTime=Tue Nov 29 23:02:32 CST 2022, time=2022-11-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1193528, encodeId=49f411935286d, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：接收后，为什么一直没有收到APC的invoice，哪位老师可以教我怎么缴纳版面费么，￣□￣｜｜，一直没有收到类似其他杂志的invoice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6155445710, createdName=HMB, createdTime=Tue Feb 15 10:58:18 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230573, encodeId=670a12305e38a, content=偏重的研究方向：乳腺癌 经验分享：记录一下 6月29日开始邀请审稿人 7月4日仍然还在邀请中........ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99c56511981, createdName=摩西摩西, createdTime=Mon Jul 04 22:29:43 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094465, encodeId=2751209446597, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：kp[k;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=614a8379235, createdName=ms3000000590360295, createdTime=Tue Oct 18 13:40:40 CST 2022, time=2022-10-18, status=1, ipAttribution=)]

2022-03-20 ms1000000553606957

Reviews returned - awaiting Editor assessment
The Editor is considering the reviews and recommendations in order to make decision on your submission这个状态已经一个多月了，需要发邮件催吗

70 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1227376, encodeId=436e122e376cb, content=偏重的研究方向：肺癌;肿瘤 经验分享：审稿3个月了，找不到审稿人，巨慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76042430158, createdName=123b4903m95暂无昵称, createdTime=Sun Jun 19 16:34:50 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227454, encodeId=c58e122e454d9, content=审稿很慢，慎投！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76042430158, createdName=123b4903m95暂无昵称, createdTime=Sun Jun 19 23:09:26 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109983, encodeId=4165210998388, content=预警风险很大啊。。。。难过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99c56511981, createdName=997xiu, createdTime=Thu Jan 12 18:17:12 CST 2023, time=2023-01-12, status=1, ipAttribution=纽约), GetPortalCommentsPageByObjectIdResponse(id=2104003, encodeId=af3721040031a, content=已经review return -awaiting editor assessment 一周了，还要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd701628022, createdName=prima, createdTime=Fri Dec 02 20:13:12 CST 2022, time=2022-12-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1204353, encodeId=807f120435326, content=Reviews returned - awaiting Editor assessment The Editor is considering the reviews and recommendations in order to make decision on your submission这个状态已经一个多月了，需要发邮件催吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34b85489817, createdName=ms1000000553606957, createdTime=Sun Mar 20 15:23:19 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104026, encodeId=3a4321040261a, content=已经review return-awaiting editor assessment一周了，还要等多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd701628022, createdName=prima, createdTime=Fri Dec 02 23:16:30 CST 2022, time=2022-12-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2103408, encodeId=f4192103408b1, content=这个是不是要预警了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=331d6510030, createdName=ms5000001864993277, createdTime=Tue Nov 29 23:02:32 CST 2022, time=2022-11-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1193528, encodeId=49f411935286d, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：接收后，为什么一直没有收到APC的invoice，哪位老师可以教我怎么缴纳版面费么，￣□￣｜｜，一直没有收到类似其他杂志的invoice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6155445710, createdName=HMB, createdTime=Tue Feb 15 10:58:18 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230573, encodeId=670a12305e38a, content=偏重的研究方向：乳腺癌 经验分享：记录一下 6月29日开始邀请审稿人 7月4日仍然还在邀请中........ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99c56511981, createdName=摩西摩西, createdTime=Mon Jul 04 22:29:43 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094465, encodeId=2751209446597, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：kp[k;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=614a8379235, createdName=ms3000000590360295, createdTime=Tue Oct 18 13:40:40 CST 2022, time=2022-10-18, status=1, ipAttribution=)]

2022-12-02 prima 来自广东省

已经review return-awaiting editor assessment一周了，还要等多久啊

45 0

[GetPortalCommentsPageByObjectIdResponse(id=1227376, encodeId=436e122e376cb, content=偏重的研究方向：肺癌;肿瘤 经验分享：审稿3个月了，找不到审稿人，巨慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76042430158, createdName=123b4903m95暂无昵称, createdTime=Sun Jun 19 16:34:50 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227454, encodeId=c58e122e454d9, content=审稿很慢，慎投！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76042430158, createdName=123b4903m95暂无昵称, createdTime=Sun Jun 19 23:09:26 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109983, encodeId=4165210998388, content=预警风险很大啊。。。。难过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99c56511981, createdName=997xiu, createdTime=Thu Jan 12 18:17:12 CST 2023, time=2023-01-12, status=1, ipAttribution=纽约), GetPortalCommentsPageByObjectIdResponse(id=2104003, encodeId=af3721040031a, content=已经review return -awaiting editor assessment 一周了，还要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd701628022, createdName=prima, createdTime=Fri Dec 02 20:13:12 CST 2022, time=2022-12-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1204353, encodeId=807f120435326, content=Reviews returned - awaiting Editor assessment The Editor is considering the reviews and recommendations in order to make decision on your submission这个状态已经一个多月了，需要发邮件催吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34b85489817, createdName=ms1000000553606957, createdTime=Sun Mar 20 15:23:19 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104026, encodeId=3a4321040261a, content=已经review return-awaiting editor assessment一周了，还要等多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd701628022, createdName=prima, createdTime=Fri Dec 02 23:16:30 CST 2022, time=2022-12-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2103408, encodeId=f4192103408b1, content=这个是不是要预警了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=331d6510030, createdName=ms5000001864993277, createdTime=Tue Nov 29 23:02:32 CST 2022, time=2022-11-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1193528, encodeId=49f411935286d, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：接收后，为什么一直没有收到APC的invoice，哪位老师可以教我怎么缴纳版面费么，￣□￣｜｜，一直没有收到类似其他杂志的invoice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6155445710, createdName=HMB, createdTime=Tue Feb 15 10:58:18 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230573, encodeId=670a12305e38a, content=偏重的研究方向：乳腺癌 经验分享：记录一下 6月29日开始邀请审稿人 7月4日仍然还在邀请中........ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99c56511981, createdName=摩西摩西, createdTime=Mon Jul 04 22:29:43 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094465, encodeId=2751209446597, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：kp[k;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=614a8379235, createdName=ms3000000590360295, createdTime=Tue Oct 18 13:40:40 CST 2022, time=2022-10-18, status=1, ipAttribution=)]

2022-11-29 ms5000001864993277 来自江苏省

这个是不是要预警了？

37 0

[GetPortalCommentsPageByObjectIdResponse(id=1227376, encodeId=436e122e376cb, content=偏重的研究方向：肺癌;肿瘤 经验分享：审稿3个月了，找不到审稿人，巨慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76042430158, createdName=123b4903m95暂无昵称, createdTime=Sun Jun 19 16:34:50 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227454, encodeId=c58e122e454d9, content=审稿很慢，慎投！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76042430158, createdName=123b4903m95暂无昵称, createdTime=Sun Jun 19 23:09:26 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109983, encodeId=4165210998388, content=预警风险很大啊。。。。难过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99c56511981, createdName=997xiu, createdTime=Thu Jan 12 18:17:12 CST 2023, time=2023-01-12, status=1, ipAttribution=纽约), GetPortalCommentsPageByObjectIdResponse(id=2104003, encodeId=af3721040031a, content=已经review return -awaiting editor assessment 一周了，还要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd701628022, createdName=prima, createdTime=Fri Dec 02 20:13:12 CST 2022, time=2022-12-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1204353, encodeId=807f120435326, content=Reviews returned - awaiting Editor assessment The Editor is considering the reviews and recommendations in order to make decision on your submission这个状态已经一个多月了，需要发邮件催吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34b85489817, createdName=ms1000000553606957, createdTime=Sun Mar 20 15:23:19 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104026, encodeId=3a4321040261a, content=已经review return-awaiting editor assessment一周了，还要等多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd701628022, createdName=prima, createdTime=Fri Dec 02 23:16:30 CST 2022, time=2022-12-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2103408, encodeId=f4192103408b1, content=这个是不是要预警了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=331d6510030, createdName=ms5000001864993277, createdTime=Tue Nov 29 23:02:32 CST 2022, time=2022-11-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1193528, encodeId=49f411935286d, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：接收后，为什么一直没有收到APC的invoice，哪位老师可以教我怎么缴纳版面费么，￣□￣｜｜，一直没有收到类似其他杂志的invoice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6155445710, createdName=HMB, createdTime=Tue Feb 15 10:58:18 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230573, encodeId=670a12305e38a, content=偏重的研究方向：乳腺癌 经验分享：记录一下 6月29日开始邀请审稿人 7月4日仍然还在邀请中........ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99c56511981, createdName=摩西摩西, createdTime=Mon Jul 04 22:29:43 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094465, encodeId=2751209446597, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：kp[k;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=614a8379235, createdName=ms3000000590360295, createdTime=Tue Oct 18 13:40:40 CST 2022, time=2022-10-18, status=1, ipAttribution=)]

2022-02-15 HMB

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤
经验分享：接收后，为什么一直没有收到APC的invoice，哪位老师可以教我怎么缴纳版面费么，￣□￣｜｜，一直没有收到类似其他杂志的invoice

148 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1227376, encodeId=436e122e376cb, content=偏重的研究方向：肺癌;肿瘤 经验分享：审稿3个月了，找不到审稿人，巨慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76042430158, createdName=123b4903m95暂无昵称, createdTime=Sun Jun 19 16:34:50 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227454, encodeId=c58e122e454d9, content=审稿很慢，慎投！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76042430158, createdName=123b4903m95暂无昵称, createdTime=Sun Jun 19 23:09:26 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109983, encodeId=4165210998388, content=预警风险很大啊。。。。难过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99c56511981, createdName=997xiu, createdTime=Thu Jan 12 18:17:12 CST 2023, time=2023-01-12, status=1, ipAttribution=纽约), GetPortalCommentsPageByObjectIdResponse(id=2104003, encodeId=af3721040031a, content=已经review return -awaiting editor assessment 一周了，还要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd701628022, createdName=prima, createdTime=Fri Dec 02 20:13:12 CST 2022, time=2022-12-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1204353, encodeId=807f120435326, content=Reviews returned - awaiting Editor assessment The Editor is considering the reviews and recommendations in order to make decision on your submission这个状态已经一个多月了，需要发邮件催吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34b85489817, createdName=ms1000000553606957, createdTime=Sun Mar 20 15:23:19 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104026, encodeId=3a4321040261a, content=已经review return-awaiting editor assessment一周了，还要等多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd701628022, createdName=prima, createdTime=Fri Dec 02 23:16:30 CST 2022, time=2022-12-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2103408, encodeId=f4192103408b1, content=这个是不是要预警了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=331d6510030, createdName=ms5000001864993277, createdTime=Tue Nov 29 23:02:32 CST 2022, time=2022-11-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1193528, encodeId=49f411935286d, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：接收后，为什么一直没有收到APC的invoice，哪位老师可以教我怎么缴纳版面费么，￣□￣｜｜，一直没有收到类似其他杂志的invoice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6155445710, createdName=HMB, createdTime=Tue Feb 15 10:58:18 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230573, encodeId=670a12305e38a, content=偏重的研究方向：乳腺癌 经验分享：记录一下 6月29日开始邀请审稿人 7月4日仍然还在邀请中........ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99c56511981, createdName=摩西摩西, createdTime=Mon Jul 04 22:29:43 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094465, encodeId=2751209446597, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：kp[k;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=614a8379235, createdName=ms3000000590360295, createdTime=Tue Oct 18 13:40:40 CST 2022, time=2022-10-18, status=1, ipAttribution=)]

2022-07-04 摩西摩西

偏重的研究方向：乳腺癌
经验分享：记录一下
6月29日开始邀请审稿人
7月4日仍然还在邀请中........

46 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=1227376, encodeId=436e122e376cb, content=偏重的研究方向：肺癌;肿瘤 经验分享：审稿3个月了，找不到审稿人，巨慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76042430158, createdName=123b4903m95暂无昵称, createdTime=Sun Jun 19 16:34:50 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227454, encodeId=c58e122e454d9, content=审稿很慢，慎投！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76042430158, createdName=123b4903m95暂无昵称, createdTime=Sun Jun 19 23:09:26 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109983, encodeId=4165210998388, content=预警风险很大啊。。。。难过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99c56511981, createdName=997xiu, createdTime=Thu Jan 12 18:17:12 CST 2023, time=2023-01-12, status=1, ipAttribution=纽约), GetPortalCommentsPageByObjectIdResponse(id=2104003, encodeId=af3721040031a, content=已经review return -awaiting editor assessment 一周了，还要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd701628022, createdName=prima, createdTime=Fri Dec 02 20:13:12 CST 2022, time=2022-12-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1204353, encodeId=807f120435326, content=Reviews returned - awaiting Editor assessment The Editor is considering the reviews and recommendations in order to make decision on your submission这个状态已经一个多月了，需要发邮件催吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34b85489817, createdName=ms1000000553606957, createdTime=Sun Mar 20 15:23:19 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2104026, encodeId=3a4321040261a, content=已经review return-awaiting editor assessment一周了，还要等多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd701628022, createdName=prima, createdTime=Fri Dec 02 23:16:30 CST 2022, time=2022-12-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2103408, encodeId=f4192103408b1, content=这个是不是要预警了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=331d6510030, createdName=ms5000001864993277, createdTime=Tue Nov 29 23:02:32 CST 2022, time=2022-11-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1193528, encodeId=49f411935286d, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：接收后，为什么一直没有收到APC的invoice，哪位老师可以教我怎么缴纳版面费么，￣□￣｜｜，一直没有收到类似其他杂志的invoice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e6155445710, createdName=HMB, createdTime=Tue Feb 15 10:58:18 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230573, encodeId=670a12305e38a, content=偏重的研究方向：乳腺癌 经验分享：记录一下 6月29日开始邀请审稿人 7月4日仍然还在邀请中........ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=99c56511981, createdName=摩西摩西, createdTime=Mon Jul 04 22:29:43 CST 2022, time=2022-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094465, encodeId=2751209446597, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：kp[k;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=614a8379235, createdName=ms3000000590360295, createdTime=Tue Oct 18 13:40:40 CST 2022, time=2022-10-18, status=1, ipAttribution=)]

2022-10-18 ms3000000590360295

审稿速度:1.0 | 投稿命中率:95.0
偏重的研究方向：肿瘤
经验分享：kp[k;

0 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务